drug
ropivacaine ER
Phase 3updated 4mo agoby $PRFX PRF Technologies Ltd.
Phase 3community read0 votes
all catalysts(2)
phase 1 2 completion · 1
Trials studying ropivacaine ER
- phase1Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
- N/AAntalgic Efficacy of CycloMesh™ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia.
- phase2Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA
- phase2Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 28, 2026
93 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Nov 28, 2026formulationUS 785780293d
- Nov 28, 2026formulationUS 785780293d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that